Spinello Antinori

Prof. Dr. Spinello Antinori

Dipartimento di Scienze Biomediche e Cliniche “Luigi Sacco”, Università di Milano, Italy
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2020 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
AGAndrea Giacomelli
Andrea Giacomelli
LPLaura Pezzati
Laura Pezzati
FCFederico Conti
Federico Conti
DBDario Bernacchia
Dario Bernacchia
MSMatteo Siano
Matteo Siano
MGMassimo Galli
Massimo Galli
To the Editor—We read with interest the article by Wang et al [1] describing the clinical features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China. The authors provide a detailed description of major signs and symptoms of overt disease [2, 3], but fail to give an account of minor symptoms that may be present at earlier stages of the infection.

9 April 2024 in The Lancet Microbe
Verified
Journal Article
Open access
GCGiacomo Casalini
Giacomo Casalini
AGAndrea Giacomelli
Andrea Giacomelli
Spinello AntinoriSpinello Antinori
Spinello Antinori
In October, 2022, WHO published the first fungal priority pathogen list, which categorised 19 fungal entities into three priority groups (critical, high, and medium), for prioritisation of research efforts. The final ranking was determined via multiple criteria decision analysis, considering both research and development needs and perceived public health importance. In this Personal View, we discuss the positioning of the fungal pathogens, namely, Mucorales, Candida spp, Histoplasma spp, Coccidioides and Paracoccidioides spp, Fusarium spp, eumycetoma causative agents, Talaromyces marneffei, and Pneumocystis jirovecii, while expressing concerns about potential disparities between the WHO fungal priority pathogen list ranking and the actual disease burden associated with these pathogens. Finally, we propose a revised prioritisation list that also considers the regional disparities in the burden of fungal diseases.

1 October 2016 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Spinello AntinoriSpinello Antinori
Spinello Antinori
LMLaura Milazzo
Laura Milazzo
SSSalvatore Sollima
Salvatore Sollima
MGMassimo Galli
Massimo Galli
MCMario Corbellino
Mario Corbellino

1 August 2020 in Pharmacological Research
Verified
Journal Article
Closed access
AGAndrea Giacomelli
Andrea Giacomelli
ARAnna Lisa Ridolfo
Anna Lisa Ridolfo
LMLaura Milazzo
Laura Milazzo
LOLetizia Oreni
Letizia Oreni
DBDario Bernacchia
Dario Bernacchia
MGMassimo Galli
Massimo Galli

1 March 2008 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
Spinello AntinoriSpinello Antinori
Spinello Antinori
Antonio CascioAntonio Cascio
Antonio Cascio
CPCarlo Parravicini
Carlo Parravicini
RBRoberto Bianchi
Roberto Bianchi
MCMario Corbellino
Mario Corbellino

11 April 2015 in Current Tropical Medicine Reports
Verified
Journal Article
Closed access
PDF file
Nathan C BahrNathan C Bahr
Nathan C Bahr
Spinello AntinoriSpinello Antinori
Spinello Antinori
LWL. Joseph J. Wheat
L. Joseph J. Wheat
GSGeorge A. Sarosi
George A. Sarosi